Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 25/2/2021
SIETES contiene 93212 citas

<< anterior 21 a 40 de 42 siguiente >>
Presentar resultados
Seleccionar todas
21. Cita con resumen
Rawaf S, De Maeseneer J, Starfield B. From Alma-Ata to Almaty: a new start for primary health care. Lancet 2008;372:1365-7. [Ref.ID 84199]
24. Cita con resumen
Spurgeon B. Opposition grows in France to new. BMJ 2007;335:1228. [Ref.ID 81787]
25. Cita con resumen
Coombes R. Cancer drugs: swallowing big pharma's line?. BMJ 2007;334:1034-5. [Ref.ID 80112]
26.Tiene citas relacionadas
Platt R, Ommaya A. A beneficial side effect of the Medicare drug benefit. N Engl J Med 2005;353:2742-3. [Ref.ID 75739]
27.Tiene citas relacionadas
Elliott RA, Majumdar SR, Gillick MR, Soumerai SB. Benefits and consequences for the poor and the disabled. N Engl J Med 2005;353:2739-41. [Ref.ID 75738]
28.Tiene citas relacionadas
Kravitz RL, Chang S. Promise and perils for patients and physicians. N Engl J Med 2005;353:2735-9. [Ref.ID 75737]
29.Tiene citas relacionadas
Bach PB, McClellan MB. A prescription for a modern Medicare program. N Engl J Med 2005;353:2733-5. [Ref.ID 75736]
Goldman DP, Joyce GF, Escarce JJ, Pace JE, Solomon MD, Laouri M, Landsman PB, Teutsch SM. Pharmacy benefits and the use of drugs by the chronically ill. JAMA 2004;291:2344-50. [Ref.ID 69983]
31. Cita con resumen
Schwenk TL. Prescription drug costs for the poor and the elderly. Journal Watch 2002;22:7. [Ref.ID 60117]
Tamblyn R, Laprise R, Hanley JA, Abrahamowicz M, Scott S, Mayo N, Hurley J, Grad R, Latimer E, Perreault R, McLeod P, Huang A, Larochelle P, Mallet L. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA 2001;285:421-9. [Ref.ID 54961]
33.Tiene citas relacionadas Cita con resumen
Price D, Pollock A M, Shaoul J. How the World Trade Organisation is shaping domestic policies in health care. Lancet 1999;354:1889-92. [Ref.ID 48319]
Anónimo. Sweden raises patient payments. Scrip 1999;2430:3. [Ref.ID 44110]
Walley T. Prescription charges: change overdue?. BMJ 1998;317:487-8. [Ref.ID 40340]
37. Cita con resumen
Garattini S. Cultural shift in Italy's drug policy. Lancet 1995;346:5-6. [Ref.ID 24525]
Burstall ML. Copayments for medicines. How much should patients pay?. Pharmacoeconomics 1994;6:187-92. [Ref.ID 22653]
39. Cita con resumen
Heath I. The creeping privatisation of NHS prescribing. BMJ 1994;309:623-4. [Ref.ID 22622]
Hux JE, Naylor C D. Drug prices and third party payment. Do they influence medication selection?. Pharmacoeconomics 1994;5:343-50. [Ref.ID 21635]
Seleccionar todas
<< anterior 21 a 40 de 42 siguiente >>